DE3017372A1 - Physiologisch aktive polysaccharide, verfahren zu ihrer herstellung sowie ihre verwendung - Google Patents

Physiologisch aktive polysaccharide, verfahren zu ihrer herstellung sowie ihre verwendung

Info

Publication number
DE3017372A1
DE3017372A1 DE19803017372 DE3017372A DE3017372A1 DE 3017372 A1 DE3017372 A1 DE 3017372A1 DE 19803017372 DE19803017372 DE 19803017372 DE 3017372 A DE3017372 A DE 3017372A DE 3017372 A1 DE3017372 A1 DE 3017372A1
Authority
DE
Germany
Prior art keywords
physiologically active
yeast
polysaccharide
water
enzyme
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
DE19803017372
Other languages
German (de)
English (en)
Inventor
Kumpei Kitamura
Shigeru Matsuki
Kozo Tanabe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kirin Brewery Co Ltd
Original Assignee
Kirin Brewery Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP54055873A external-priority patent/JPS5857153B2/ja
Priority claimed from JP5587479A external-priority patent/JPS55147224A/ja
Application filed by Kirin Brewery Co Ltd filed Critical Kirin Brewery Co Ltd
Publication of DE3017372A1 publication Critical patent/DE3017372A1/de
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/005—Glycopeptides, glycoproteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
    • C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
    • C07K14/395—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts from Saccharomyces
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14—Fungi; Culture media therefor
    • C12N1/16—Yeasts; Culture media therefor
    • C12N1/18—Baker's yeast; Brewer's yeast
    • C12N1/185—Saccharomyces isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/02—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using fungi
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/645—Fungi ; Processes using fungi
    • C12R2001/85—Saccharomyces
    • C12R2001/865—Saccharomyces cerevisiae

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Botany (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Epidemiology (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Medical Informatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DE19803017372 1979-05-08 1980-05-07 Physiologisch aktive polysaccharide, verfahren zu ihrer herstellung sowie ihre verwendung Withdrawn DE3017372A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP54055873A JPS5857153B2 (ja) 1979-05-08 1979-05-08 制癌性物質の製造法
JP5587479A JPS55147224A (en) 1979-05-08 1979-05-08 Carcinostatic agent

Publications (1)

Publication Number Publication Date
DE3017372A1 true DE3017372A1 (de) 1980-11-20

Family

ID=26396775

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19803017372 Withdrawn DE3017372A1 (de) 1979-05-08 1980-05-07 Physiologisch aktive polysaccharide, verfahren zu ihrer herstellung sowie ihre verwendung

Country Status (4)

Country Link
US (1) US4313934A (enExample)
DE (1) DE3017372A1 (enExample)
FR (1) FR2455893A1 (enExample)
GB (1) GB2048918B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008201A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur gewinnung hochmolekularer biologisch aktiver immunmodulierender polysaccharide aus hefe saccharomyces cerevisiae

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH654210A5 (it) * 1983-05-20 1986-02-14 Hasunor Ag Procedimento per ottenere preparati metabolicamente attivi ottenuti da lievito di qualsiasi tipo.
EP0295961A3 (en) * 1987-06-18 1989-07-12 Kureha Kagaku Kogyo Kabushiki Kaisha Polysaccharides and antiviral drug containing polysaccharides as active ingredient
US6093552A (en) * 1990-12-03 2000-07-25 Laine; Roger A. Diagnosis of fungal infections with a chitinase
DE4336888A1 (de) * 1993-10-28 1995-05-04 Thiemann Arzneimittel Gmbh Produkt, erhältlich aus Hefezellen von Saccharomyces boulardii und dessen Verwendung
AUPN398295A0 (en) * 1995-07-05 1995-07-27 Carlton And United Breweries Limited Chemical compounds and processes for their production
DE60040548D1 (de) * 1999-07-21 2008-11-27 Yakult Honsha Kk Mittel zur senkung von cholesterin, mittel zur hemmung der produktion von sekundären gallensäuren, nahrungsmittel und getränke
US6975892B2 (en) * 2003-10-21 2005-12-13 Oculir, Inc. Methods for non-invasive analyte measurement from the conjunctiva
US6968222B2 (en) 2003-05-02 2005-11-22 Oculir, Inc. Methods and device for non-invasive analyte measurement
US6958039B2 (en) * 2003-05-02 2005-10-25 Oculir, Inc. Method and instruments for non-invasive analyte measurement
US20060224057A1 (en) * 2003-10-21 2006-10-05 Oculir, Inc. Methods for non-invasive analyte measurement
US20060258919A1 (en) * 2004-04-14 2006-11-16 Oculir, Inc. Non-Invasive Analyte Measurement Device for Measuring Tears and Other Ocular Elements Using Electromagnetic Radiation and Method of Using the Same
US20080009688A1 (en) * 2004-04-14 2008-01-10 Oculir, Inc. Methods for non-invasive analyte measurement
CN101184780B (zh) * 2005-05-05 2012-10-03 森馨香料公司 β-葡聚糖和甘露聚糖的制备
FI20070471A0 (fi) * 2007-06-13 2007-06-13 Glykos Finland Oy Ravinnelisäkompositiota
RU2406516C1 (ru) * 2009-06-09 2010-12-20 Общество с ограниченной ответственностью "Фитолокомотив" Профилактический антибактериальный препарат и способ его получения
CN111718429B (zh) * 2020-07-21 2022-08-05 暨南大学 一种菇类食用菌多糖及其制备方法和应用

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2273067A1 (en) * 1974-05-31 1975-12-26 Anvar Bacterial cell treatment - by autolysis in absence of added enzymes
FR2320107A1 (fr) * 1975-08-05 1977-03-04 Anvar Nouveaux adjuvants immunologiques, procede pour leur obtention et compositions les contenant
FR2321896A1 (fr) * 1975-08-29 1977-03-25 Anvar Agents adjuvants immunologiques actifs en solution aqueuse
DE2603122C3 (de) * 1976-01-28 1980-04-17 Hans H. Dr. 2000 Hamburg Nagel Verfahren zum Herstellen von Glykoproteinen sowie deren Verwendung
JPS5344614A (en) * 1976-10-04 1978-04-21 Ebios Pharma Antitumor agent
FR2378855A1 (fr) * 1977-01-27 1978-08-25 Cassenne Lab Sa Nouvelles glycoproteines isolees d'hafnia, procede de preparation et application a titre de medicaments
JPS5715712A (en) * 1980-06-30 1982-01-27 Mitsubishi Heavy Ind Ltd Sluice gate tilting toward upstream side

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000008201A1 (de) * 1998-08-07 2000-02-17 Kulicke Werner Michael Verfahren zur gewinnung hochmolekularer biologisch aktiver immunmodulierender polysaccharide aus hefe saccharomyces cerevisiae

Also Published As

Publication number Publication date
FR2455893A1 (fr) 1980-12-05
GB2048918B (en) 1983-03-30
US4313934A (en) 1982-02-02
GB2048918A (en) 1980-12-17
FR2455893B1 (enExample) 1983-07-29

Similar Documents

Publication Publication Date Title
DE3017372A1 (de) Physiologisch aktive polysaccharide, verfahren zu ihrer herstellung sowie ihre verwendung
DE69431024T2 (de) Neues physiologisch aktives Mittel
DE2751570A1 (de) Carboxymethylierte beta-1,3-glucane, verfahren zu deren herstellung und antitumormittel
DE3448155C2 (enExample)
EP0213099A2 (de) Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen
DE2659808B2 (de) Proteingebundene Polysaccharide und deren Verwendung zur Bekämpfung von Tumoren
DE3109335C2 (de) Ebelacton A und B, Verfahren zu deren Herstellung und diese Verbindungen enthaltende pharmazeutische Mittel
DE2731570B2 (de) Verfahren zur Gewinnung eines Polysaccharide mit therapeutischer Wirkung
DE2926406A1 (de) Praeparat zur behandlung maligner neoplasien und verfahren zu seiner herstellung
DE2919132A1 (de) Substanz ks-2-b, verfahren zu deren herstellung und diese substanz enthaltende mittel
DD215580A5 (de) Hypocholesterolaemisch aktives protein
DE2825464A1 (de) Biologisch aktive substanz, verfahren zu deren herstellung und dieselbe enthaltendes pharmazeutisches mittel
DE2137011C3 (de) Verfahren zur Gewinnung reinen Konjakumannans und daraus hergestelltes pharmazeutisches Präparat
DE2209834A1 (de) Herstellung eines saccharaseinhibitors
DE3881198T2 (de) Antiviraler wirkstoff.
DE3409029C2 (enExample)
DE69107815T2 (de) Verfahren zur Herstellung neuer nichtkovalenten Polysaccharid-Protein-Zusammensetzungen mit pharmakologischen Eigenschaften.
DD222895A5 (de) Verfahren zur herstellung eines hypotriglyceridemisch aktiven polysaccharids
DE2829975A1 (de) Antitumor wirksame substanz, deren herstellung und verwendung
EP0395851B1 (de) Glykoproteine aus Avena sativa, Verfahren zu ihrer Herstellung und ihre Verwendung als pharmazeutischer Wirkstoff
DE2028403A1 (de) Pepstatin
DE3204631A1 (de) Therapeutisches mittel und dessen verwendung
DE2803681C2 (enExample)
DE2146674C3 (de) Faktor und seine Verwendung als Arzneimittel
DE1767099B1 (de) Verfahren zur Gewinnung eines Glykoproteins mit einer Hemmwirkung gegenueber Magensaeureabsonderung und einer Antiaktivitaet gegenueber Ulcus-Bildung

Legal Events

Date Code Title Description
8141 Disposal/no request for examination